Home › Idiopathic Thrombocytopenic Purpura › Minnesota
Idiopathic Thrombocytopenic Purpura clinical trials in Minnesota
5 studies for Idiopathic Thrombocytopenic Purpura are looking for participants at sites in Minnesota.
Cities in Minnesota
A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)
- Mayo Clinic Rochester, Rochester
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT07421167A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
- Mayo Clinic, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06721013Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07549698Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment
- Mayo Clinic_Investigational Site Number: 8400009, Rochester
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 22, 2026 · NCT07007962A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia
- University of Minnesota, Minneapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 1, 2026 · NCT06544499From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.